Autopsy report · NCT03369782

Effect of NMBA on Surgical Conditions in THR

“refocusing of research priorities”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Algemeen Ziekenhuis Maria Middelares

Sponsor type

University, hospital or other

Conditions

Surgery; Postoperative Pain

Interventions

Rocuronium; Sugammadex; Placebo

Participants

0

Sites

1

Countries

Belgium

Trials that died the same way

• Diazoxide Suppression Test P&F Study
  “Reprioritization of research efforts” (67% match in meaning)
• SHIFT: Studying HIV Immunology After Fecal Transplant
  “The study closed because of shifting research priorities and interests.” (60% match in meaning)
• Oral Rehydration Solution and Dehydration Recovery
  “Change in Research Focus” (58% match in meaning)
• The Effects of Injection Site Cooling and Solution Buffering on Perceived Pain During Local Anesthesia Administration
  “Shift in research focus” (57% match in meaning)
• Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
  “The study was stopped due to a realignment of strategic priorities” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.